INX-315
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INX-315, covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer [Phase 1, Phase 2]